Cargando…

ATM Inhibitor Suppresses Gemcitabine-Resistant BTC Growth in a Polymerase θ Deficiency-Dependent Manner

Patients with advanced biliary tract cancer (BTC) inevitably experience progression after first-line, gemcitabine-based chemotherapy, due to chemo-resistance. The genetic alterations of DNA damage repair (DDR) genes are usually determined in BTC tumors. In this study, we found that the POLQ mRNA lev...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pan, Yi-Ru, Wu, Chiao-En, Yeh, Chun-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7697425/ https://www.ncbi.nlm.nih.gov/pubmed/33182492 http://dx.doi.org/10.3390/biom10111529

Ejemplares similares

Targeting P53 as a Future Strategy to Overcome Gemcitabine Resistance in Biliary Tract Cancers
por: Wu, Chiao-En, et al.
Publicado: (2020)

Multifaceted Nature of DNA Polymerase θ
por: Kruchinin, Alexander A., et al.
Publicado: (2023)

Promiscuous DNA synthesis by human DNA polymerase θ
por: Hogg, Matthew, et al.
Publicado: (2012)

Polymerase θ inhibition steps on the cGAS pedal
por: Smith, Chelsea M., et al.
Publicado: (2023)

Cutting Edge Research for Exploration of Biomolecules for Gemcitabine-Based Chemo-Resistant Advanced Bile Duct Cancer: From Basic Study to Clinical Trial
por: Wu, Chiao-En, et al.
Publicado: (2021)

DNA Polymerase θ Increases Mutational Rates in Mitochondrial DNA
por: Wisnovsky, Simon, et al.
Publicado: (2018)

Defining the mutation signatures of DNA polymerase θ in cancer genomes
por: Hwang, Taejoo, et al.
Publicado: (2020)

Transformation and regeneration of DNA polymerase Θ mutant rice plants
por: Nishizawa‐Yokoi, Ayako, et al.
Publicado: (2023)

DNA Polymerase θ: A Unique Multifunctional End-Joining Machine
por: Black, Samuel J., et al.
Publicado: (2016)

Structural basis of DNA polymerase θ mediated DNA end joining
por: Li, Chuxuan, et al.
Publicado: (2022)

Targeting polymerase θ impairs tumorigenesis and enhances radiosensitivity in lung adenocarcinoma
por: Rao, Xinrui, et al.
Publicado: (2023)

ALDH1A1 promotes PARP inhibitor resistance by enhancing retinoic acid receptor-mediated DNA polymerase θ expression
por: Lavudi, Kousalya, et al.
Publicado: (2023)

Human DNA polymerase θ grasps the primer terminus to mediate DNA repair
por: Zahn, Karl E., et al.
Publicado: (2015)

One-step enzymatic modification of RNA 3′ termini using polymerase θ
por: Thomas, Crystal, et al.
Publicado: (2019)

DNA Polymerase θ: A Cancer Drug Target with Reverse Transcriptase Activity
por: Chen, Xiaojiang S., et al.
Publicado: (2021)

Polymerase θ Coordinates Multiple Intrinsic Enzymatic Activities during DNA Repair
por: Zahn, Karl E., et al.
Publicado: (2021)

Polymerase θ inhibition activates the cGAS-STING pathway and cooperates with immune checkpoint blockade in models of BRCA-deficient cancer
por: Patterson-Fortin, Jeffrey, et al.
Publicado: (2023)

Polθ Inhibition: An Anticancer Therapy for HR-Deficient Tumours
por: Barszczewska-Pietraszek, Gabriela, et al.
Publicado: (2022)

DNA polymerases ν and θ are required for efficient immunoglobulin V gene diversification in chicken
por: Kohzaki, Masaoki, et al.
Publicado: (2010)

DNA polymerase θ specializes in incorporating synthetic expanded-size (xDNA) nucleotides
por: Kent, Tatiana, et al.
Publicado: (2016)

CuBTC Metal–Organic Framework Decorated with FeBTC Nanoparticles with Enhance Water Stability for Environmental Remediation Applications
por: Kim, Donghun, et al.
Publicado: (2023)

Identification of Synaptic DGKθ Interactors That Stimulate DGKθ Activity
por: Barber, Casey N., et al.
Publicado: (2022)

Individual Cytokines Modulate the Neurological Symptoms of ATM Deficiency in a Region Specific Manner1,2,3
por: Hui, Chin Wai, et al.
Publicado: (2015)

Simulation of beam-photoelectron interactions in BTcF
por: Zhang, C, et al.
Publicado: (1996)

On θ(ω) continuity
por: Al Ghour, Samer, et al.
Publicado: (2020)

Polymerase Θ is a key driver of genome evolution and of CRISPR/Cas9-mediated mutagenesis
por: van Schendel, Robin, et al.
Publicado: (2015)

Mucin 4 Confers Gemcitabine Resistance and an Unfavorable Prognosis in Patients with Cholangiocarcinoma via AKT Activation
por: Pan, Yi-Ru, et al.
Publicado: (2023)

ATM-Deficient Colorectal Cancer Cells Are Sensitive to the PARP Inhibitor Olaparib()
por: Wang, Chen, et al.
Publicado: (2017)

Safety and feasibility of toripalimab plus lenvatinib with or without radiotherapy in advanced BTC
por: Wang, Yunchao, et al.
Publicado: (2023)

Haploinsufficiency of Bcl11b suppresses the progression of ATM-deficient T cell lymphomas
por: Pinkney, Kerice A., et al.
Publicado: (2015)

A study on beam-beam interactions for BTcF
por: Zhang, C, et al.
Publicado: (1998)

Synthesis of bimetallic–organic framework Cu/Co-BTC and the improved performance of thiophene adsorption
por: Tian, Fuping, et al.
Publicado: (2019)

Polθ inhibitors elicit BRCA-gene synthetic lethality and target PARP inhibitor resistance
por: Zatreanu, Diana, et al.
Publicado: (2021)

DNA Damage Activates the SAC in an ATM/ATR-Dependent Manner, Independently of the Kinetochore
por: Kim, Eun Mi, et al.
Publicado: (2008)

Novel targets for ATM-deficient malignancies
por: Winkler, Johannes, et al.
Publicado: (2014)

Polymerase θ is a robust terminal transferase that oscillates between three different mechanisms during end-joining
por: Kent, Tatiana, et al.
Publicado: (2016)

DNA polymerase θ-mediated repair of high LET radiation-induced complex DNA double-strand breaks
por: Yi, Geunil, et al.
Publicado: (2023)

Characteristics and Treatment of Breakthrought Pain (BTcP) in Palliative Care
por: Husic, Samir, et al.
Publicado: (2017)

LSTM in Algorithmic Investment Strategies on BTC and S&P500 Index
por: Michańków, Jakub, et al.
Publicado: (2022)

Synthesis and analytical characterization of Ca-BTC metal organic framework
por: Ramzan, Munazza, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_334ia0rkbe6tc4fkg2njj03s8l